Trends in the use of radiation protection and radiation exposure of European endourologists: a prospective trial from the EULIS-YAU Endourology Group.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 20 11 2023
accepted: 06 02 2024
medline: 18 3 2024
pubmed: 15 3 2024
entrez: 15 3 2024
Statut: epublish

Résumé

Due to the radiation exposure for the urology staff during endourology, our aim was to evaluate the trends of radiation protection in the operation room by endourologists from European centers and to estimate their annual radiation. We conducted a multicenter study involving experienced endourologists from different European centers to evaluate whether the protection and threshold doses recommended by the International Commission on Radiation Protection (ICRP) were being followed. A 36-question survey was completed on the use of fluoroscopy and radiation protection. Annual prospective data from chest, extremities, and eye dosimeters were collected during a 4-year period (2017-2020). Ten endourologists participated. Most surgeons use lead aprons and thyroid shield (9/10 and 10/10), while leaded gloves and caps are rarely used (2/10 both). Six out of ten surgeons wear leaded glasses. There is widespread use of personal chest dosimeters under the apron (9/10), and only 5/10 use a wrist or ring dosimeter and 4 use an eye dosimeter. Two endourologists use the ALARA protocol. The use of ultrasound and fluoroscopy during PCNL puncture was reported by 8 surgeons. The mean number of PCNL and URS per year was 30.9 (SD 19.9) and 147 (SD 151.9). The mean chest radiation was 1.35 mSv per year and 0.007 mSv per procedure. Mean radiation exposure per year in the eyes and extremities was 1.63 and 11.5 mSv. Endourologists did not exceed the threshold doses for radiation exposure to the chest, extremities and lens. Furthermore, the ALARA protocol manages to reduce radiation exposure.

Identifiants

pubmed: 38488927
doi: 10.1007/s00345-024-04854-0
pii: 10.1007/s00345-024-04854-0
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

163

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Medical and Dental Guidance Notes (2002) A good practice guide on all aspects of ionising radiation protection in the clinical environment. J Radiol Prot 22(3):334–335. https://doi.org/10.1088/0952-4746/22/3/705
doi: 10.1088/0952-4746/22/3/705
Stewart FA, Akleyev AV, Hauer-Jensen M, Hendry JH, Kleiman NJ, MacVittie TJ et al (2012) ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs — threshold doses for tissue reactions in a radiation protection context. Ann ICRP 41(1–2):1–322. https://doi.org/10.1016/j.icrp.2012.02.001
doi: 10.1016/j.icrp.2012.02.001 pubmed: 22925378
Emiliani E, Kanashiro A, Chi T, Pérez-Fentes DA, Manzo BO, Angerri O et al (2020) Fluoroless endourological surgery for stone disease: a review of the literature—tips and tricks. Curr Urol Rep 21(7):27. https://doi.org/10.1007/s11934-020-00979-y
doi: 10.1007/s11934-020-00979-y pubmed: 32444987
Coppeta L, Pietroiusti A, Neri A, Spataro A, De Angelis E, Perrone S et al (2019) Risk of radiation-induced lens opacities among surgeons and interventional medical staff. Radiol Phys Technol 12(1):26–29. https://doi.org/10.1007/s12194-018-0487-9
doi: 10.1007/s12194-018-0487-9 pubmed: 30478501
Chodick G, Bekiroglu N, Hauptmann M, Alexander BH, Freedman DM, Doody MM et al (2008) Risk of cataract after exposure to low doses of ionizing radiation: a 20-year prospective cohort study among US radiologic technologists. Am J Epidemiol 168(6):620–631. https://doi.org/10.1093/aje/kwn171
doi: 10.1093/aje/kwn171 pubmed: 18664497 pmcid: 2727195
Doizi S, Audouin M, Villa L, Rodríguez-Monsalve Herrero M, De Coninck V, Keller EX et al (2019) The eye of the endourologist: what are the risks? A review of the literature. World J Urol 37(12):2639–2647. https://doi.org/10.1007/s00345-019-02667-0
doi: 10.1007/s00345-019-02667-0 pubmed: 30737574
Alazzoni A, Gordon CL, Syed J, Natarajan MK, Rokoss M, Schwalm J-D et al (2015) Randomized controlled trial of radiation protection with a patient lead shield and a novel, nonlead surgical cap for operators performing coronary angiography or intervention. Circ Cardiovasc Interv. https://doi.org/10.1161/CIRCINTERVENTIONS.115.002384
doi: 10.1161/CIRCINTERVENTIONS.115.002384 pubmed: 26253734
Grabowicz W, Masiarek K, Górnik T, Grycewicz T, Brodecki M, Dabin J et al (2022) The effect of lead free cap on the doses of ionizing radiation to the head of interventional cardiologists working in haemodynamic room. Int J Occup Med Environ Health 35(5):549–560
doi: 10.13075/ijomeh.1896.01958 pubmed: 35446304 pmcid: 10464785
Zöller G, Figel M, Denk J, Schulz K, Sabo A (2016) Strahlenbelastung der Augenlinse bei ureterorenoskopischen Eingriffen ohne und mit Strahlenschutzvisier. Urologe 55(3):364–369. https://doi.org/10.1007/s00120-015-3921-1
doi: 10.1007/s00120-015-3921-1
Hartmann J, Distler F, Baumüller M, Guni E, Pahernik S, Wucherer M (2018) Risk of radiation-induced cataracts: investigation of radiation exposure to the eye lens during endourologic procedures. J Endourol 32(10):897–903. https://doi.org/10.1089/end.2018.0324
doi: 10.1089/end.2018.0324 pubmed: 29901404
Patel R, Dubin J, Olweny EO, Elsamra SE, Weiss RE (2017) Use of fluoroscopy and potential long-term radiation effects on cataract formation. J Endourol 31(9):825–828. https://doi.org/10.1089/end.2016.0454
doi: 10.1089/end.2016.0454 pubmed: 28707955
Taylor ER, Kramer B, Frye TP, Wang S, Schwartz BF, Köhler TS (2013) Ocular radiation exposure in modern urological practice. J Urol 190(1):139–143. https://doi.org/10.1016/j.juro.2013.01.081
doi: 10.1016/j.juro.2013.01.081 pubmed: 23376142
Chartier H, Fassier P, Leuraud K, Jacob S, Baudin C, Laurier D et al (2020) Occupational low-dose irradiation and cancer risk among medical radiation workers. Occup Med (Chic Ill) 70(7):476–484
doi: 10.1093/occmed/kqaa130
Hellawell GO, Mutch SJ, Thevendran G, Wells E, Morgan RJ (2005) Radiation exposure and the urologist: what are the risks? J Urol 174(3):948–952. https://doi.org/10.1097/01.ju.0000170232.58930.8f
doi: 10.1097/01.ju.0000170232.58930.8f pubmed: 16094003
Majidpour HS (2010) Risk of radiation exposure during PCNL. Urol J 7(2):87–89
pubmed: 20535693
Balaji SS, Vijayakumar M, Singh AG, Ganpule AP, Sabnis RB, Desai MR (2019) Analysis of factors affecting radiation exposure during percutaneous nephrolithotomy procedures. BJU Int 124(3):514–521. https://doi.org/10.1111/bju.14833
doi: 10.1111/bju.14833 pubmed: 31140706
International Atomic Energy Agency (2006) Applying radiation safety standards in diagnostic radiology and interventional procedures using X rays. Saf Rep Ser 39
Galonnier F, Traxer O, Rosec M, Terrasa J-B, Gouezel P, Celier D et al (2016) Surgical staff radiation protection during fluoroscopy-guided urologic interventions. J Endourol 30(6):638–643. https://doi.org/10.1089/end.2016.0022
doi: 10.1089/end.2016.0022 pubmed: 26987619
Hayashi S, Takenaka M, Kogure H, Yakushijin T, Maruyama H, Hori Y et al (2021) A questionnaire survey on radiation protection among 282 medical staff from 26 endoscopy-fluoroscopy departments in Japan. DEN Open. https://doi.org/10.1002/deo2.5
doi: 10.1002/deo2.5 pubmed: 35310733 pmcid: 8828251
Altintas E, Bahceci T, Batur AF, Kaynar M, Kilic O, Akand M et al (2021) A survey analysis of knowledge levels of urologists about radiation safety and fluoroscopy use. Int J Clin Pract. https://doi.org/10.1111/ijcp.13862
doi: 10.1111/ijcp.13862 pubmed: 34228870
Söylemez H, Altunoluk B, Bozkurt Y, Sancaktutar AA, Penbegül N, Atar M (2012) Radiation exposure—Do urologists take it seriously in Turkey? J Urol 187(4):1301–1305. https://doi.org/10.1016/j.juro.2011.11.110
doi: 10.1016/j.juro.2011.11.110 pubmed: 22341291
Borges CF, Reggio E, Vicentini FC, Reis LO, Carnelli GR, Fregonesi A (2015) How are we protecting ourselves from radiation exposure? A nationwide survey. Int Urol Nephrol 47(2):271–274. https://doi.org/10.1007/s11255-014-0882-z
doi: 10.1007/s11255-014-0882-z pubmed: 25398647
Vassileva J, Zagorska A, Karagiannis A, Petkova K, Sabuncu K, Saltirov I et al (2021) Radiation exposure of surgical team during endourological procedures: International Atomic Energy Agency–South-Eastern European Group for Urolithiasis Research Study. J Endourol 35(5):574–582. https://doi.org/10.1089/end.2020.0630
doi: 10.1089/end.2020.0630 pubmed: 32791856
Ong K, Warren H, Nalagatla S, Kmiotek E, Obasi C, Shanmugathas N et al (2021) Radiation safety knowledge and practice in urology theaters: a collaborative multicenter survey. J Endourol 35(7):1084–1089. https://doi.org/10.1089/end.2020.0955
doi: 10.1089/end.2020.0955 pubmed: 33544020
Dudley AG, Semins MJ (2015) Radiation practice patterns and exposure in the high-volume endourologist. Urology 85(5):1019–1024
doi: 10.1016/j.urology.2014.11.060 pubmed: 25917725
Sparenborg J, Yingling C (2016) Determining fluoroscopic radiation exposure to the urology resident. Omi J Radiol 05(01):215
Bhanot R, Hameed ZBM, Shah M, Juliebø-Jones P, Skolarikos A, Somani B (2022) ALARA in urology: steps to minimise radiation exposure during all parts of the endourological journey. Curr Urol Rep 23(10):255–259. https://doi.org/10.1007/s11934-022-01102-z
doi: 10.1007/s11934-022-01102-z pubmed: 35962267 pmcid: 9569289
Elkoushy MA, Shahrour W, Andonian S (2012) Pulsed fluoroscopy in ureteroscopy and percutaneous nephrolithotomy. Urology 79(6):1230–1235
doi: 10.1016/j.urology.2012.01.027 pubmed: 22465084
Güner B, Günaydın B (2019) Retrograde intrarenal surgery without fluoroscopy: Is it possible? A randomized prospective study, an extraordinary experience. Actas Urológicas Españolas (English Ed) 43(10):521–525
Agarwal M, Agrawal MS, Jaiswal A, Kumar D, Yadav H, Lavania P (2011) Safety and efficacy of ultrasonography as an adjunct to fluoroscopy for renal access in percutaneous nephrolithotomy (PCNL). BJU Int 108(8):1346–1349. https://doi.org/10.1111/j.1464-410X.2010.10002.x
doi: 10.1111/j.1464-410X.2010.10002.x pubmed: 21251187
Basiri A, Ziaee AM, Kianian HR, Mehrabi S, Karami H, Moghaddam SMH (2008) Ultrasonographic versus fluoroscopic access for percutaneous nephrolithotomy: a randomized clinical trial. J Endourol 22(2):281–284. https://doi.org/10.1089/end.2007.0141
doi: 10.1089/end.2007.0141 pubmed: 18294034
Arabzadeh Bahri R, Maleki S, Shafiee A, Shobeiri P (2023) Ultrasound versus fluoroscopy as imaging guidance for percutaneous nephrolithotomy: a systematic review and meta-analysis. PLoS One 18(3):e0276708. https://doi.org/10.1371/journal.pone.0276708
doi: 10.1371/journal.pone.0276708 pubmed: 36862676 pmcid: 9980746
Stam W, Pillay M (2008) Inspection of lead aprons: a practical rejection model. Health Phys 95(2):S133–S136
doi: 10.1097/01.HP.0000314763.19226.86 pubmed: 18617796
Michel R, Zorn MJ (2002) Implementation of an X-ray radiation protective equipment inspection program. Health Phys 82:S51–S53
doi: 10.1097/00004032-200202001-00012 pubmed: 11797906
Matsuda M, Suzuki T (2016) Evaluation of lead aprons and their maintenance and management at our hospital. J Anesth 30(3):518–521. https://doi.org/10.1007/s00540-016-2140-2
doi: 10.1007/s00540-016-2140-2 pubmed: 26842670

Auteurs

Sofia Fontanet Soler (S)

Department of Urology, Fundació Puigvert (IUNA), Autonoma University of Barcelona, Barcelona, Spain. sofia.fontanet@gmail.com.

Alejandra Bravo-Balado (A)

Department of Urology, Fundació Puigvert (IUNA), Autonoma University of Barcelona, Barcelona, Spain.

Andreas Skolarikos (A)

Department of Urology, Sismanogleio Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Christian Seitz (C)

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Olivier Traxer (O)

Department of Urology, Tenon Hospital, Hôpitaux Universitaires Paris-EST, Assistance Publique Hôpitaux de Paris, Université Pierre Et Marie Curie Paris 6, Paris, France.

Michele Talso (M)

Department of Urology ASST Fatebenefratelli, Sacco University Hospital, Milan, Italy.

Eugenio Ventimiglia (E)

Department of Urology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Luca Villa (L)

Department of Urology, URI, IRCCS Ospe-Dale San Raffaele, Milan, Italy.

Amelia Pietropaolo (A)

Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Etienne Xavier Keller (EX)

Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Panagiotis Kallidonis (P)

Department of Urology, University Hospital of Rion, Patras, Greece.

Tarik Emre Sener (TE)

Department of Urology, School of Medicine, Marmara University, Istanbul, Turkey.

Udo Nagele (U)

Department of Urology and Andrology, General Hospital Hall in Tirol, Hall in Tirol, Austria.

Vincent De Coninck (V)

Department of Urology, AZ Klina, Brasschaat, Belgium.

Zeeshan Hameed (Z)

Department of Urology, Kasturba Medical College Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Arman Tsaturyan (A)

Department of Urology, University of Patras, Patras, Greece.

Patrick Juliebø-Jones (P)

Department of Urology, Haukeland University Hospital, Bergen, Norway.

Ioannis Mikoniatis (I)

Department of Urology, Faculty of Medicine, Aristotle University of Thessaloniki School of Health Sciences, Thessaloniki, Greece.

Oliver Wiseman (O)

Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Lazaros Tzelves (L)

Department of Urology, Sismanogleio Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Esteban Emiliani (E)

Department of Urology, Fundació Puigvert (IUNA), Autonoma University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH